# Iridia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iridia

- Industry: Biotechnology
- Headquarters: Carlsbad, US
- Website: www.iridia.com
- Total disclosed funding: $24M
- Latest round: Series B (Mar 16, 2021)
- Investors on record: 9

## About

Iridia, Inc. develops advanced molecular technology that enhances security and authenticity across industries. Their solutions are crucial in combating counterfeiting and ensuring provenance in high-value goods.Founded in 2016, Iridia, Inc. is based in Carlsbad, US and specializes in molecular technology. They raised USD 6.00 mn in a funding round from Prime Movers Lab in November 2021, which contributes to their ongoing development. The company has completed five deals to date.Iridia.com specializes in advanced molecular technology designed to enhance security and authenticity across multiple industries. The company's core product offerings include invisible, tamper-proof molecular identifiers that are embedded within various items, providing a unique signature that ensures provenance and combats counterfeiting. These solutions serve a diverse clientele, including luxury retailers, art institutions, and manufacturers within the aerospace and defense sectors. Iridia's technology is particularly valuable for luxury goods, sports memorabilia, and critical infrastructure, enabling businesses to safeguard their assets and elevate customer experiences. The geographical markets for these products include North America, Europe, and Asia, where they address the growing need for secure authentication and traceability in high-value sectors.Iridia.com generates revenue through a combination of direct sales and strategic partnerships with businesses in luxury retail, art, and defense industries. Transactions typically involve the integration of their molecular technology into client offerings, allowing for enhanced product verification and customer engagement. The company structures its revenue model around B2B relationships, where clients purchase the technology for embedding into their products or services. Flagship offerings include proprietary molecular identification solutions that are tailored to specific industry needs, facilitating premium pricing strategies that reflect the high value of security and authenticity. The revenue model may also encompass long-term contracts with clients seeking to implement continuous monitoring and verification services, further emphasizing the ongoing value of Iridia's technology.In November 2021, Iridia, Inc. raised USD 6.00 mn in venture funding from Prime Movers Lab. This funding will be utilized to accelerate the development of working prototypes, marking a significant step toward commercialization. The company plans to expand its market presence, targeting new regions and industries to broaden the application of its molecular technology.

## Funding rounds

- Series B, Mar 16, 2021, $24M — Western Digital Capital, Tech Coast Angels, ATEM Capital, Validus Growth Investors, JSR, North Sound Ventures, LifeSci Partners, Longley Capital, Pritzker Vlock Family Office

## Investors

- Western Digital Capital (https://capitalatlas.ai/funds/western-digital-capital) — Series B
- Tech Coast Angels — Series B
- ATEM Capital (https://capitalatlas.ai/funds/atem-capital) — Series B
- Validus Growth Investors — Series B
- JSR — Series B
- North Sound Ventures (https://capitalatlas.ai/funds/north-sound-ventures) — Series B
- LifeSci Partners (https://capitalatlas.ai/funds/lifesci-partners) — Series B
- Longley Capital (https://capitalatlas.ai/funds/longley-capital) — Series B
- Pritzker Vlock Family Office (https://capitalatlas.ai/funds/pritzker-vlock-family-office) — Series B